<i>CHEK2</i>*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast CancerMaren Weischer, Annegien Broeks, Montserrat García‐Closas et al.|Journal of Clinical Oncology|2012Cited by 180
<i>CDH1</i> mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer riskHaixin Lei, Igor Vořechovský, Sara Margolin et al.|International Journal of Cancer|2001Cited by 88
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyJieping Lei, Veli‐Matti Kosma, Anja Rudolph et al.|Breast Cancer Research|2015Cited by 24